Cornerstone National Bank & Trust’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-166
Closed -$158K 221
2026
Q1
$158K Sell
166
-8
-5% -$8.11K 0.06% 83
2025
Q4
$187K Buy
174
+8
+5% +$7.65K 0.07% 70
2025
Q3
$127K Sell
166
-56
-25% -$41.7K 0.05% 72
2025
Q2
$173K Sell
222
-1
-0.4% -$777 0.07% 66
2025
Q1
$184K Buy
+223
New +$186K 0.08% 64
2023
Q1
Sell
-4,171
Closed -$1.53M 57
2022
Q4
$1.53M Sell
4,171
-141
-3% -$50K 0.85% 17
2022
Q3
$1.39M Sell
4,312
-117
-3% -$37.1K 0.76% 17
2022
Q2
$1.44M Buy
4,429
+15
+0.3% +$4.5K 0.72% 17
2022
Q1
$1.26M Sell
4,414
-166
-4% -$42.7K 0.56% 31
2021
Q4
$1.27M Sell
4,580
-2
-0% -$507 0.55% 29
2021
Q3
$1.06M Buy
4,582
+104
+2% +$25.7K 0.47% 32
2021
Q2
$1.03M Buy
4,478
+323
+8% +$64.9K 0.45% 32
2021
Q1
$776K Sell
4,155
-901
-18% -$176K 0.36% 37
2020
Q4
$854K Buy
5,056
+107
+2% +$16K 0.46% 36
2020
Q3
$733K Sell
4,949
-819,892
-99% -$127M 0.47% 37
2020
Q2
$825K Buy
824,841
+818,911
+13,810% +$126M 0.6% 28
2020
Q1
$823K Sell
5,930
-1,208
-17% -$166K 0.74% 21
2019
Q4
$938K Buy
+7,138
New +$827K 0.84% 24

Other funds holding LLY

Cornerstone National Bank & Trust's LLY Position: Q2 2026 in Review

Cornerstone National Bank & Trust sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 166 shares — an estimated $158K sold.

Cornerstone National Bank & Trust first reported a position in LLY in Q4 2019 and held it in 18 quarters. The position peaked at $1.53M in Q4 2022. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Cornerstone National Bank & Trust reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
  • Cornerstone National Bank & Trust sold 166 Eli Lilly shares in Q2 2026, an estimated $158K.
  • Cornerstone National Bank & Trust first reported a position in Eli Lilly in Q4 2019 and held it in 18 quarters.
  • Cornerstone National Bank & Trust's Eli Lilly position peaked at $1.53M in Q4 2022.
  • 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Cornerstone National Bank & Trust's 13F filing for Q2 2026, filed 21 Jul 2026.